Market Place
Sourcing Support
Gpp Generic Valganciclovir Hydrochloride Receives Approval in US
11 Jun 2024 //
FDA
Hetero`s Generic Valganciclovir Hydrochloride Receives Approval in the U.S.
04 Oct 2022 //
FDA
Valganciclovir leads to low blood counts in kidney transplant recipients
22 Feb 2022 //
PHARMABIZ
Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
02 Dec 2021 //
BUSINESSWIRE
Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
23 Nov 2021 //
BUSINESSWIRE
FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus
08 Oct 2021 //
ENDPTS
Mylan`s Generic Valganciclovir Hydrochloride Receives Approval In US
06 Mar 2021 //
FDA
Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application
09 Jul 2020 //
PRNEWSWIRE
5 FDA-approved antivirals could target COVID-19: study
02 Jul 2020 //
FIERCE BIOTECH
Viracta Therapeutics Announces Orphan Drug Designation Granted
24 Jun 2020 //
PRNEWSWIRE
Granules Pharms Generic Valganciclovir Hydrochloride Receives Approval In US
06 Feb 2020 //
FDA
Granules India arm gets USFDA nod for Valganciclovir hydrochloride oral solution
04 Feb 2020 //
MONEYCONTROL
Ajanta Pharma`s Generic Valganciclovir Hydrochloride Receive Approval in U.S
14 Jan 2020 //
FDA
Ajanta Pharma`s Generic Valganciclovir Hydrochloride Receives Approval In Us
03 Jan 2020 //
FDA
Sun Pharma gets partial relief from US court in litigation on generic drugs
03 Dec 2019 //
BUSINESS-STANDARD
Takeda’s CMV med outshines Roche’s Valcyte in phase 2
25 Sep 2019 //
FIERCE BIOTECH
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Cipla`s Generic Valganciclovir Hydrochloride Receives Approval in US
12 Nov 2018 //
FDA
Enforcement Report - Week of March 21, 2018
21 Mar 2018 //
FDA
Dr Reddys Lab’s Generic Valganciclovir Hydrochloride Receives Approval In US
17 Dec 2017 //
FDA
Actavis Receives FDA Nod For Valganciclovir To Treat CMV Infections
19 Jul 2016 //
FDA
Aurobindo Pharma gets final USFDA nod for anti-viral drug
31 Mar 2016 //
ECONOMIC TIMES
Despite Drug Trial Failure, Are Chimerix Shares Due For A Rebound?
31 Dec 2015 //
FORBES
India rejects Swiss drug maker Roche Patent claims on Valcyte again
24 Jul 2015 //
ECONOMIC TIMES HEALTHWORLD
US lawsuit puts generic drug imports from India under scanner
16 May 2015 //
THE ECONOMIC TIMES
Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews
28 Apr 2015 //
FIERCE PHARMA ASIA
U.S. Judge Denies Ranbaxy Bid To Reinstate Approvals For Valcyte, Nexium Copies
03 Mar 2015 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.